The potential application of encapsulated exosomes: A new approach to increase exosomes therapeutic efficacy.

Cancer Drug loading Encapsulation Exosome Infectious disease Regenerative medicine

Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 24 02 2023
revised: 24 03 2023
accepted: 27 03 2023
medline: 3 5 2023
pubmed: 4 4 2023
entrez: 3 4 2023
Statut: ppublish

Résumé

Cell therapy is one of the methods that have shown promising results in treating diseases in recent decades. However, the use of different types of cells comes with limitations. The application of immune cells in cell therapy can lead to cytokine storms and inappropriate responses to self-antigens. Also, the use of stem cells has the potential to create tumors. Also, cells may not migrate to the injury site after intravenous injection. Therefore, using exosomes from different cells as therapeutic candidates were proposed. Due to their small size and favorable characteristics, such as biocompatibility and immunocompatibility, the easy storage and isolation, exosomes have attracted much attention. They are used in treating many diseases, including cardiovascular diseases, orthopedic diseases, autoimmune diseases, and cancer. However, the results of various studies have shown that the therapeutic efficiency of exosomes (Exo) can be increased by loading different drugs and microRNAs inside them (encapsulated exosomes). Therefore, analyzing studies investigating encapsulated exosomes' therapeutic ability is critical. In this study, we have examined the studies related to the use of encapsulated exosomes in treating diseases such as cancer and infectious diseases and their use in regenerative medicine. Compared to intact exosomes, the results show that the application of encapsulated exosomes has a higher therapeutic ability. Therefore it is suggested to use this method depending on the treatment type to increase the treatment's efficiency.

Identifiants

pubmed: 37011484
pii: S0753-3322(23)00403-1
doi: 10.1016/j.biopha.2023.114615
pii:
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114615

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no competing interests.

Auteurs

Ali Hazrati (A)

Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Zahra Mirsanei (Z)

Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Neda Heidari (N)

Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Kosar Malekpour (K)

Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Nasim Rahmani-Kukia (N)

Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Ardeshir Abbasi (A)

Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Sara Soudi (S)

Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: soudi@modares.ac.ir.

Articles similaires

Organoids Humans Tissue Engineering Coculture Techniques Regenerative Medicine
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition
Curcumin Spinal Cord Injuries Humans Animals Neural Stem Cells

Classifications MeSH